Caballero Jorge A. 4
Research Summary
AI-generated summary
AMN Director Jorge A. Caballero Receives RSUs; Converts Derivatives
What Happened Jorge A. Caballero, a director of AMN Healthcare Services, recorded derivative conversions/vests and a new RSU award dated May 1, 2026. The filing shows (1) a conversion/exercise of derivative securities (code M) for 8,325 shares at $0.00 (acquired) and a corresponding disposition of 8,325 derivative units at $0.00, and (2) a grant/award (code A) of 8,304 Restricted Stock Units (RSUs) at $0.00. These were non-cash equity events (vesting/conversion and a new RSU grant), not open-market purchases or sales.
Key Details
- Transaction date: May 1, 2026; Form 4 filed May 4, 2026 (timely filing).
- Prices: all reported at $0.00 (reflecting vesting/conversion and grant, not cash transactions).
- Shares involved: 8,325 (derivative conversion/vest) and 8,304 (new RSU award).
- Footnotes: the 8,325 shares relate to RSUs vesting (granted May 2, 2025 under the 2017 Equity Plan); the 8,304 RSUs were granted May 1, 2026 under the 2025 Equity Plan and vest the earlier of one year or the next annual meeting. RSUs have no expiration.
- Shares owned after the transaction: not disclosed in the provided data.
Context Code M denotes exercise or conversion of a derivative; here it reflects conversion/vesting of previously granted RSUs into common stock (hence both an acquisition of shares and a disposition of the derivative instrument). Code A denotes an award/grant (new RSUs). These types of filings are routine equity-compensation events and do not represent open-market buying or selling.